234 related articles for article (PubMed ID: 20420180)
1. [Crow-Fukase (POEMS) syndrome].
Kuwabara S
Brain Nerve; 2010 Apr; 62(4):395-400. PubMed ID: 20420180
[TBL] [Abstract][Full Text] [Related]
2. [New treatment strategy for Crow-Fukase (POEMS) syndrome].
Kuwabara S
Rinsho Shinkeigaku; 2010 Nov; 50(11):794-6. PubMed ID: 21921444
[TBL] [Abstract][Full Text] [Related]
3. [Electrophysiologic aspects of Crow-Fukase (POEMS) syndrome--significance in early diagnosis and insights into the pathophysiology].
Misawa S
Brain Nerve; 2008 Jun; 60(6):595-601. PubMed ID: 18567354
[TBL] [Abstract][Full Text] [Related]
4. [Crow-Fukase (POEMS) syndrome: pathophysiology and treatments].
Kuwabara S
Nihon Rinsho; 2013 May; 71(5):865-9. PubMed ID: 23777096
[TBL] [Abstract][Full Text] [Related]
5. [Advances and perspectives in treatment for refractory neuropathies with special reference to immune-mediated neuropathies and Crow-Fukase syndrome].
Kuwabara S
Rinsho Shinkeigaku; 2010 Apr; 50(4):219-24. PubMed ID: 20411803
[TBL] [Abstract][Full Text] [Related]
6. [New strategy of treatment for POEMS syndrome--autologous peripheral blood stem cell transplantation and thalidomide therapy].
Kuwabara S
Brain Nerve; 2008 Jun; 60(6):627-33. PubMed ID: 18567358
[TBL] [Abstract][Full Text] [Related]
7. [Crow-Fukase syndrome and VEGF].
Arimura K; Hashiguchi T; Watanabe O
Brain Nerve; 2008 Jun; 60(6):611-9. PubMed ID: 18567356
[TBL] [Abstract][Full Text] [Related]
8. [Treatment strategy for POEMS syndrome].
Kawamura N; Kira J
Brain Nerve; 2008 Jun; 60(6):621-6. PubMed ID: 18567357
[TBL] [Abstract][Full Text] [Related]
9. [POEMS syndrome (or Crow-Fukase syndrome)].
Lagueny A; Bouillot S; Vital C; Ferrer X; Larrieu JM; Vital A
Rev Neurol (Paris); 2004 Mar; 160(3):285-95. PubMed ID: 15037841
[TBL] [Abstract][Full Text] [Related]
10. [POEMS syndrome: monoclonal plasma cell disorder with polyneuropathy].
Kamezaki K; Nagafuji K
Nihon Rinsho; 2007 Dec; 65(12):2235-7. PubMed ID: 18069266
[TBL] [Abstract][Full Text] [Related]
11. [Increased vascular endothelial growth factor (VEGF) is causative in Crow-Fukase syndrome].
Arimura K
Rinsho Shinkeigaku; 1999 Jan; 39(1):84-5. PubMed ID: 10377815
[TBL] [Abstract][Full Text] [Related]
12. [Crow-Fukase (POEMS) syndrome].
Kuwabara S
Nihon Rinsho; 2015 Sep; 73 Suppl 7():446-51. PubMed ID: 26480740
[No Abstract] [Full Text] [Related]
13. Overproduction of vascular endothelial growth factor/vascular permeability factor is causative in Crow-Fukase (POEMS) syndrome.
Watanabe O; Maruyama I; Arimura K; Kitajima I; Arimura H; Hanatani M; Matsuo K; Arisato T; Osame M
Muscle Nerve; 1998 Nov; 21(11):1390-7. PubMed ID: 9771661
[TBL] [Abstract][Full Text] [Related]
14. New advances in the diagnosis and treatment of POEMS syndrome.
Li J; Zhou DB
Br J Haematol; 2013 May; 161(3):303-15. PubMed ID: 23398538
[TBL] [Abstract][Full Text] [Related]
15. [Crow-Fukase syndrome (POEMS syndrome)].
Iwashita H
Brain Nerve; 2011 Feb; 63(2):131-9. PubMed ID: 21301037
[TBL] [Abstract][Full Text] [Related]
16. Failure of treatment with anti-VEGF monoclonal antibody for long-standing POEMS syndrome.
Kanai K; Kuwabara S; Misawa S; Hattori T
Intern Med; 2007; 46(6):311-3. PubMed ID: 17380000
[TBL] [Abstract][Full Text] [Related]
17. Crow-Fukase syndrome.
Koike H; Sobue G
Neuropathology; 2000 Sep; 20 Suppl():S69-72. PubMed ID: 11037192
[TBL] [Abstract][Full Text] [Related]
18. [Rapid improvement of fluid retention with lenalidomide plus low-dose dexamethasone for POEMS syndrome relapsed after autologous peripheral blood stem cell transplantation].
Ohashi K; Yokoyama A; Kagoo T; Hosoda T; Yamamoto R; Yoneda M; Kudo M; Boku S; Ueno H; Yano T
Rinsho Ketsueki; 2013 Jul; 54(7):670-4. PubMed ID: 23912352
[TBL] [Abstract][Full Text] [Related]
19. Successful combination treatment with bevacizumab, thalidomide and autologous PBSC for severe POEMS syndrome.
Ohwada C; Nakaseko C; Sakai S; Takeda Y; Abe D; Takeuchi M; Sakaida E; Masuda S; Shimizu N; Cho R; Nishimura M; Kanai K; Misawa S; Kuwabara S
Bone Marrow Transplant; 2009 May; 43(9):739-40. PubMed ID: 19043459
[No Abstract] [Full Text] [Related]
20. Ambiguous effects of anti-VEGF monoclonal antibody (bevacizumab) for POEMS syndrome.
Sekiguchi Y; Misawa S; Shibuya K; Nasu S; Mitsuma S; Iwai Y; Beppu M; Sawai S; Ito S; Hirano S; Nakaseko C; Kuwabara S
J Neurol Neurosurg Psychiatry; 2013 Dec; 84(12):1346-8. PubMed ID: 23463868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
